Aims and methods: In this double-blind, double-dummy, randomised, parallel group, multicentre study, the efficacy of dosing and re-dosing of a fixed combination of indomethacin, prochlorperazine and caffeine (Indoprocaf) was compared with encapsulated sumatriptan in the acute treatment of two migraine attacks. Additionally, in the group taking Indoprocaf, two different oral formulations were tested: effervescent tablets and encapsulated coated tablets. Results: Of 297 patients randomised (150 assigned to Indoprocaf and 147 to sumatriptan), 281 were included in the intention-to-treat efficacy analysis. The initial dosing of Indoprocaf and sumatriptan was similarly effective with pain-free rates higher than 30% (95% CI of odds-ratio: 0.57-1.28) and headache relief rates of about 60% (95% CI of odds-ratio: 0.82-1.84) with both the drugs. The efficacy of re-dosing of Indoprocaf as rescue medication was more effective than that of sumatriptan with pain-free values of 47% vs. 27% in the total attacks with a statistically significant difference in the first migraine attack in favour of Indoprocaf. The efficacy of re-dosing to treat a recurrence/relapse was very high without differences between the drugs (pain-free: 60% with Indoprocaf and 50% with sumatriptan in the total attacks). Indoprocaf and sumatriptan were well-tolerated. Conclusions: The study demonstrated that the efficacy of the initial dosing of Indoprocaf was not higher than that of sumatriptan, but that the strategy to use the lowest effective dose as soon as the headache occurred, followed by a second dose if the headache has not relieved or to treat a relapse, was very effective, especially with Indoprocaf.
Efficacy of dosing and re-dosing of two oral fixed combinations of indomethacin, prochlorperazine and caffeine compared with oral sumatriptan in the acute treatment of multiple migraine attacks: a double-blind, double-dummy, randomised, parallel group, multicentre study / G., Sandrini; R., Cerbo; A., Del Bene; Ferrari, Anna; S., Genco; I., Grazioli; P., Martelletti; G., Nappi; L., Pinessi; P., Sarchielli; P., Tamburro; C., Uslenghi; G., Zanchin. - In: INTERNATIONAL JOURNAL OF CLINICAL PRACTICE. - ISSN 1368-5031. - STAMPA. - 61(8)(2007), pp. 1256-1269.
Data di pubblicazione: | 2007 |
Titolo: | Efficacy of dosing and re-dosing of two oral fixed combinations of indomethacin, prochlorperazine and caffeine compared with oral sumatriptan in the acute treatment of multiple migraine attacks: a double-blind, double-dummy, randomised, parallel group, multicentre study |
Autore/i: | G., Sandrini; R., Cerbo; A., Del Bene; Ferrari, Anna; S., Genco; I., Grazioli; P., Martelletti; G., Nappi; L., Pinessi; P., Sarchielli; P., Tamburro; C., Uslenghi; G., Zanchin |
Autore/i UNIMORE: | |
Digital Object Identifier (DOI): | http://dx.doi.org/10.1111/j.1742-1241.2007.01458.x |
Rivista: | |
Volume: | 61(8) |
Pagina iniziale: | 1256 |
Pagina finale: | 1269 |
Codice identificativo ISI: | WOS:000247906500008 |
Codice identificativo Scopus: | 2-s2.0-34447341670 |
Codice identificativo Pubmed: | 17627707 |
Citazione: | Efficacy of dosing and re-dosing of two oral fixed combinations of indomethacin, prochlorperazine and caffeine compared with oral sumatriptan in the acute treatment of multiple migraine attacks: a double-blind, double-dummy, randomised, parallel group, multicentre study / G., Sandrini; R., Cerbo; A., Del Bene; Ferrari, Anna; S., Genco; I., Grazioli; P., Martelletti; G., Nappi; L., Pinessi; P., Sarchielli; P., Tamburro; C., Uslenghi; G., Zanchin. - In: INTERNATIONAL JOURNAL OF CLINICAL PRACTICE. - ISSN 1368-5031. - STAMPA. - 61(8)(2007), pp. 1256-1269. |
Tipologia | Articolo su rivista |
File in questo prodotto:
File | Descrizione | Tipologia | |
---|---|---|---|
Efficacy of dosing and re-dosing of two oral fixed.pdf | Post-print dell'autore (bozza post referaggio) | Administrator Richiedi una copia |

I documenti presenti in Iris Unimore sono rilasciati con licenza Creative Commons Attribuzione - Non commerciale - Non opere derivate 3.0 Italia, salvo diversa indicazione.
In caso di violazione di copyright, contattare Supporto Iris